³í¹®) Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer ¿¬¼¼¾Ïº´¿ø Á¾¾ç³»°ú Á¶º´Ã¶ ±³¼ö´Ô°ú Á¦¿í¾Ï¿¬±¸¼Ò À±¹Ì¶õ ¹Ú»ç ¿¬±¸ÆÀ